简介：
Overview
This protocol describes a rapid and cost-effective method for in ovo xenografting of patient-derived B- and T-acute lymphoblastic leukemia (ALL) cells. The model allows for the exploration of leukemia progression and drug response within a limited timeframe.
Key Study Components
Area of Science
- Cancer Biology
- Leukemia Research
- Preclinical Drug Screening
Background
- Acute lymphoblastic leukemia (ALL) is a type of cancer affecting blood and bone marrow.
- The in ovo model provides a unique platform for studying leukemia.
- Short experimental windows limit long-term studies.
- Patient-derived xenografts can enhance the relevance of preclinical models.
Purpose of Study
- To establish a method for in ovo xenografting of ALL cells.
- To facilitate preclinical applications in leukemia research.
- To explore personalized medicine approaches in treating leukemia.
Methods Used
- Transfer of procured eggs into a humidified rolling incubator.
- Maintaining humidity at 50 to 60% and temperature at 39 degrees Celsius.
- Injection of patient-derived B- and T-ALL cells.
- Observation of xenograft development over a 10-day period.
Main Results
- Successful establishment of in ovo xenografts from patient-derived cells.
- Feasibility for preclinical drug screening demonstrated.
- Potential for mechanistic studies in leukemia progression.
- Insights into personalized treatment strategies for ALL.
Conclusions
- The in ovo xenograft model is a promising tool for leukemia research.
- This method allows for rapid assessment of drug responses.
- Further studies can enhance understanding of leukemia biology.
What is the significance of using patient-derived cells?
Using patient-derived cells enhances the relevance of the model to human disease, allowing for better insights into treatment responses.
How long can the xenograft be studied?
The experimental window for the in ovo model is approximately 10 days, which limits long-term studies.
What are the potential applications of this model?
This model can be used for preclinical drug screening, mechanistic studies, and exploring personalized medicine approaches.
What conditions are required for incubating the eggs?
The eggs should be kept in a humidified rolling incubator at 50 to 60% humidity and a temperature of 39 degrees Celsius.
What types of leukemia cells can be used in this protocol?
Both B-cell and T-cell lineages of acute lymphoblastic leukemia can be xenografted using this protocol.
What are the advantages of the in ovo model?
The in ovo model allows for a controlled environment and rapid assessment of leukemia progression and drug responses.
繁體中文
